Dr Esther Arwert is working on identifying treatments to enhance the immunotherapy options available to people with breast cancer.
Dr Arwert leads our Functional Tumour Immunology Group, which is part of our Centre for Immunotherapy of Cancer. Her research aims to successfully harness the body’s immune system to control and destroy the disease.
Such treatments could benefit many thousands of women with breast cancer, including those with faulty BRCA genes as well as more common non-hereditary forms of the disease.
